Skip to main content
CriticalFDAfda-F-1866-2017LISTERIA

Hamden, 3.5 lbs. wrapped in paper Vulto Creamery, Walton, NY.

⚠ Critical Alert — Stop Using Immediately

This product has been flagged with severe risks (listeria). Stop using it now and contact the brand or FDA for a refund, repair, or replacement.

Category
Units Affected
75
Recall Date
March 6, 2017
Issuing Agency
Hazard
Listeria

FDA Recall Notice

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-1866-2017.

Firm was notified by their supplier that the product may be contaminated with Listeria monocytogenes.

Corrective Action (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-1866-2017.

Recall terminated by FDA.

✅ What you should do

  1. Stop using the product if you own it.
  2. Check the model number, lot code, or sell-by date against the recall notice above.
  3. Contact Tomales Bay Foods, Inc. or the retailer where you bought it for a refund, replacement, or repair.
  4. For the most current official instructions, visit the FDA recall page.
  5. If you've been hurt by this product, report the incident to FDA.

Consumer Contact (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-1866-2017.

Tomales Bay Foods, Inc.

FDA

About the U.S. Food and Drug Administration

The FDA regulates drugs, medical devices, food, cosmetics, and tobacco. Adverse event reports and recall notices are the main public safety signal.

Visit FDA.gov →

📣 Report a food, supplement, or cosmetic problem to the FDA

If you had a reaction, found contamination, or experienced a labeling problem with this product, report it to the FDA. The agency uses consumer reports to track emerging safety signals and trigger recalls.

How to report to FDAFile a report at FDA

Tomales Bay Foods, Inc. Recall FAQ

Tomales Bay Foods, Inc. is the subject of a food safety report: Hamden, 3.5 lbs. wrapped in paper Vulto Creamery, Walton, NY.. The notice was published on March 6, 2017 by the U.S. Food and Drug Administration (FDA). Approximately 75 units are potentially affected.